Skip to menu Skip to content Skip to footer

2025

Conference Publication

Safety-Driven Ocrelizumab Discontinuation vs Continuation: Comparative Insights from MSBase

D'Amico, Emanuele, Zanghi, Aurora, Spelman, Tim, Kermode, Allan G., Pedrini, Marzena, Carroll, William, Lechner-Scott, Jeannette, van der Walt, Anneke, Butzkueven, Helmut, John, Nevin A., Kalincik, Tomas, Roos, Izanne, Boz, Cavit, Ozakbas, Serkan, Barnett, Michael, Hodgkinson, Suzanne, Habek, Mario, Buzzard, Katherine, Skibina, Olga, Grammond, Pierre, Alroughani, Raed, Laureys, Guy, Horakova, Dana, Havrdova, Eva, Izquierdo, Guillermo H., Eichau, Sara, Mccombe, Pamela, Massey, Jennifer, Aragon de Vecino, Maria Cecilia ... Gerlach, Oliver (2025). Safety-Driven Ocrelizumab Discontinuation vs Continuation: Comparative Insights from MSBase. 41st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Barcelona Spain, Sep 24-26, 2025. LONDON: SAGE PUBLICATIONS LTD.

Safety-Driven Ocrelizumab Discontinuation vs Continuation: Comparative Insights from MSBase

2025

Conference Publication

Real-World Management of Multiple Sclerosis after Cancer Chemotherapy

Nesbitt, Cassie, Sanfilippo, Paul, Zhu, Chao, Ozakbas, Serkan, Prat, Alexandre, Girard, Marc, Duquette, Pierre, Kalincik, Tomas, Roos, Izanne, Buzzard, Katherine, Skibina, Olga, Foschi, Matteo, Surcinelli, Andrea, Boz, Cavit, Scott, Jeannette Lechner, Libertinova, Jana, Patti, Francesco, Kermode, Allan, Carroll, William, Barnett, Michael, Hodgkinson, Suzanne, Grand'Maison, Francois, Horakova, Dana, Havrdova, Eva, Blanco, Yolanda, Hradilek, Pavel, Vachova, Marta, Habek, Mario, Maimone, Davide ... Jokubaitis, Vilija (2025). Real-World Management of Multiple Sclerosis after Cancer Chemotherapy. 41st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Barcelona Spain, Sep 24-26, 2025. LONDON: SAGE PUBLICATIONS LTD.

Real-World Management of Multiple Sclerosis after Cancer Chemotherapy

2025

Conference Publication

Treatment strategies after cell-trafficking agents in MS patients older than 50 years

Muller, Jannis, Benkert, Pascal, Horakova, Dana, Havrdova, Eva, Buzzard, Katherine, Skibina, Olga, Ozakbas, Serkan, Lechner Scott, Jeannette, Izquierdo Ayuso, Guillermo, Eichau, Sara, Weinstock-Guttman, Bianca, Hodgkinson, Suzanne, Grammond, Pierre, Barnett, Michael, Prat, Alexandre, Girard, Marc, Duquette, Pierre, van der Walt, Anneke, Butzkueven, Helmut, John, Nevin A., Meca-Lallana, Jose E., Prevost, Julie, Gerlach, O., Boz, Cavit, McCombe, Pamela, Lugaresi, Alessandra, Tomassini, Valentina, Kermode, Allan, Pedrini, Marzena ... Roos, Izanne (2025). Treatment strategies after cell-trafficking agents in MS patients older than 50 years. 41st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Barcelona Spain, Sep 24-26, 2025. LONDON: SAGE PUBLICATIONS LTD.

Treatment strategies after cell-trafficking agents in MS patients older than 50 years

2025

Conference Publication

Late-Onset Multiple Sclerosis: Do High-Efficacy Treatments Deliver Better Outcomes?

Foong, Yi Chao, Merlo, Daniel, Gresle, Melissa, Buzzard, Katherine, Horakova, Dana, Havrdova, Eva, Kalincik, Tomas, Roos, Izanne, Hodgkinson, Suzanne, Scott, Jeannette Lechner, Lugaresi, Alessandra, Weinstock-Guttman, Bianca, Ozakbas, Serkan, Surcinelli, Andrea, Foschi, Matteo, Boz, Cavit, Khoury, Samia, Yamout, Bassem, Laureys, Guy, Blanco, Yolanda, Skibina, Olga, Kuhle, Jens, John, Nevin A., Alroughani, Raed, Prevost, Julie, Van Pesch, Vincent, Tomassini, Valentina, Prat, Alexandre, Terzi, Murat ... van der Walt, Anneke (2025). Late-Onset Multiple Sclerosis: Do High-Efficacy Treatments Deliver Better Outcomes?. 41st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Barcelona Spain, Sep 24-26, 2025. LONDON: SAGE PUBLICATIONS LTD.

Late-Onset Multiple Sclerosis: Do High-Efficacy Treatments Deliver Better Outcomes?

2025

Conference Publication

Machine Learning-Generated Longitudinal Synthetic International Data in Multiple Sclerosis

Iqbal, Hassam, Qiang, Zhe, Sharmin, Sifat, Ball, Gareth, Brankovic, Aida, Horakova, Dana, Havrdova, Eva, Ozakbas, Serkan, Shaygannejad, Vahid, Karabudak, Rana, Patti, Francesco, Zamzam, Dina, Alroughani, Raed, Etemadifar, Masoud, Boz, Cavit, Ayuso, Guillermo Izquierdo, Eichau, Sara, Terzi, Murat, Prat, Alexandre, Girard, Marc, Duquette, Pierre, Amato, Maria Pia, Grand'Maison, Francois, Kermode, Allan, Pedrini, Marzena, Carroll, William, Yamout, Bassem I., Khoury, Samia, Shalaby, Nevin ... Kalincik, Tomas (2025). Machine Learning-Generated Longitudinal Synthetic International Data in Multiple Sclerosis. 41st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Barcelona Spain, Sep 24-26, 2025. LONDON: SAGE PUBLICATIONS LTD.

Machine Learning-Generated Longitudinal Synthetic International Data in Multiple Sclerosis

2025

Conference Publication

Effectiveness of autologous haematopoietic stem cell transplant in comparison with anti-CD20 therapies in relapsing-remitting multiple sclerosis

Kalincik, Tomas, Sharmin, Sifat, Roos, Izanne, Freedman, Mark S., Atkins, Harold, Massey, Jennifer, Sutton, Ian, Withers, Barbara, Burman, Joachim, Torkildsen, Oivind, Bo, Lars, Lehmann, Anne Kristine, Havrdova, Eva, Krasulova, Eva, Trneny, Marek, Kozak, Tomas, Macdonell, Richard, Brown, J. William L., Coles, Alasdair, van der Walt, Anneke, Butzkueven, Helmut, Scott, Jeannette Lechner, Van Wijmeersch, Bart, Barnett, Michael, Laureys, Guy, Willekens, Barbara, Buzzard, Katherine, Skibina, Olga, Di Gregorio, Maria ... Snowden, John (2025). Effectiveness of autologous haematopoietic stem cell transplant in comparison with anti-CD20 therapies in relapsing-remitting multiple sclerosis. 41st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Barcelona Spain, Sep 24-26, 2025. LONDON: SAGE PUBLICATIONS LTD.

Effectiveness of autologous haematopoietic stem cell transplant in comparison with anti-CD20 therapies in relapsing-remitting multiple sclerosis

2025

Conference Publication

Real-World Insights on Ofatumumab in Australian RMS Patients: MSBase Registry Analysis

Butzkueven, Helmut, van der Walt, Anneke, Spelman, Tim, Kermode, Allan, Pedrini, Marzena, Carroll, William, Scott, Jeannette Lechner, John, Nevin A., Barnett, Michael, Hodgkinson, Suzanne, McCombe, Pamela, Kalincik, Tomas, Macdonell, Richard, Slee, Mark, Buzzard, Katherine, Nelson, Morag, Schmitt, Birte and Martel, Kate (2025). Real-World Insights on Ofatumumab in Australian RMS Patients: MSBase Registry Analysis. 41st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Barcelona Spain, Sep 24-26, 2025. LONDON: SAGE PUBLICATIONS LTD.

Real-World Insights on Ofatumumab in Australian RMS Patients: MSBase Registry Analysis

2025

Conference Publication

Causal effects of multiple sclerosis therapies in left-truncated registry data

Haile, Dagmawi, Diouf, Ibrahima, Ozakbas, Serkan, Horakova, Dana, Havrdova, Eva, Patti, Francesco, Izquierdo Ayuso, Guillermo, Eichau, Sara, Alroughani, Raed, Lugaresi, Alessandra, Tomassini, Valentina, Boz, Cavit, Prat, Alexandre, Girard, Marc, Duquette, Pierre, Buzzard, Katherine, Skibina, Olga, Yamout, Bassem I., Terzi, Murat, Khoury, Samia, Grammond, Pierre, Scott, Jeannette Lechner, Blanco, Yolanda, Shaygannejad, Vahid, Foschi, Matteo, Surcinelli, Andrea, Neri, Stefano, Weinstock-Guttman, Bianca, Prevost, Julie ... Kalincik, Tomas (2025). Causal effects of multiple sclerosis therapies in left-truncated registry data. 41st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Barcelona Spain, Sep 24-26, 2025. LONDON: SAGE PUBLICATIONS LTD.

Causal effects of multiple sclerosis therapies in left-truncated registry data

2025

Conference Publication

From Data to Diagnosis: Harmonizing RRMS and SPMS Classification via AI Models on Global and National Scales

Sreenivasan, Akshai Parakkal, Sharmin, Sifat, Noui, Yassine, Ozakbas, Serkan, Etemadifar, Masoud, Alroughani, Raed, Shaygannejad, Vahid, Patti, Francesco, Boz, Cavit, Brown, J. William L., Coles, Alasdair, Prat, Alexandre, Girard, Marc, Duquette, Pierre, Yamout, Bassem I., Khoury, Samia, Ayuso, Guillermo Izquierdo, Eichau, Sara, Terzi, Murat, Roos, Izanne, Scott, Jeannette Lechner, Buzzard, Katherine, Skibina, Olga, Grammond, Pierre, Habek, Mario, Zakaria, Magd Fouad, Amato, Maria Pia, Prevost, Julie, Gerlach, O. ... Kultima, Kim (2025). From Data to Diagnosis: Harmonizing RRMS and SPMS Classification via AI Models on Global and National Scales. 41st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Barcelona Spain, Sep 24-26, 2025. LONDON: SAGE PUBLICATIONS LTD.

From Data to Diagnosis: Harmonizing RRMS and SPMS Classification via AI Models on Global and National Scales

2025

Conference Publication

Cladribine as an exit strategy in people with MS over the age of 50

Roos, Izanne, Sharmin, Sifat, Mueller, Jannis, Horakova, Dana, Havrdova, Eva, Ozakbas, Serkan, Prat, Alexandre, Girard, Marc, Duquette, Pierre, Libertinova, Jana, Mares, Miroslav, Grammond, Pierre, Prevost, Julie, Rous, Zuzana, Scott, Jeannette Lechner, Buzzard, Katherine, Skibina, Olga, Hradilek, Pavel, van der Walt, Anneke, Butzkueven, Helmut, Boz, Cavit, Patti, Francesco, Barnett, Michael, Izquierdo Ayuso, Guillermo, Eichau, Sara, Blanco, Yolanda, Meca-Lallana, Jose E., Foschi, Matteo, Surcinelli, Andrea ... Kalincik, Tomas (2025). Cladribine as an exit strategy in people with MS over the age of 50. 41st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Barcelona Spain, Sep 24-26, 2025. LONDON: SAGE PUBLICATIONS LTD.

Cladribine as an exit strategy in people with MS over the age of 50

2024

Conference Publication

The risk of secondary progressive multiple sclerosis is geographically determined but modifiable

Sharmin, Sifat, Roos, Izanne, Simpson-Yap, Steve, Malpas, Charles, Lechner-Scott, Jeannette, Buzzard, Katherine, Skibina, Olga, van der Walt, Anneke, Butzkueven, Helmut, Kermode, Allan, Butler, Ernest, Barnett, Michael, Hodgkinson, Suzanne, McCombe, Pamela, Taylor, Bruce, Slee, Mark, Macdonell, Richard, Garber, Justin, Shaw, Cameron, Shuey, Neil, Massey, Jennifer, Hardy, Todd, Parratt, John and Kalincik, Tomas (2024). The risk of secondary progressive multiple sclerosis is geographically determined but modifiable. Multiple Sclerosis Australia: Progress in MS Research Conference (MS), Perth, WA, Australia, 29 November - 1 December 2023. London, United Kingdom: Sage Publications.

The risk of secondary progressive multiple sclerosis is geographically determined but modifiable

2024

Conference Publication

DNA methylation discriminates between responder and non-responder status in a long-term study of cladribine tablet use in multiple sclerosis

Maltby, Vicki E., Xavier, Alexandre, Monif, Mastura, Min, Myintzu, Fabis-Pedrini, Marzena J., Buzzard, Katherine, Kalincik, Tomas, Kermode, Allan G., Taylor, Bruce, Hodgkinson, Suzanne, McCombe, Pamela, Osborne, Meaghan, Butzkueven, Helmut, Barnett, Michael, Lea, Rodney A. and Lechner-Scott, Jeannette (2024). DNA methylation discriminates between responder and non-responder status in a long-term study of cladribine tablet use in multiple sclerosis. Multiple Sclerosis Australia: Progress in MS Research Conference (MS), Perth, WA, Australia, 29 November - 1 December 2023. London, United Kingdom: Sage Publications.

DNA methylation discriminates between responder and non-responder status in a long-term study of cladribine tablet use in multiple sclerosis

2024

Conference Publication

Closing the gap in diagnosis of neuropathies and late-onset neurological disorders - a trans-Australia collaboration

Laing, N., Kennerson, M., Lamont, P., Vucic, S., Davis, M., Bryson-Richardson, R., Ravenscroft, G., Perez-Siles, G., Ghaoui, R., Narayanan, R., McCombe, P., Deveson, I., Bryen, S., Grosz, B., Johari, M., Rick, A., Folland, C., Scriba, C., Parmar, J. and Ellis, M. (2024). Closing the gap in diagnosis of neuropathies and late-onset neurological disorders - a trans-Australia collaboration. 29th International Congress of the World-Muscle-Society (WMS), Prague, Czech Republic, 8-12 October 2024. London, United Kingdom: Elsevier. doi: 10.1016/j.nmd.2024.07.328

Closing the gap in diagnosis of neuropathies and late-onset neurological disorders - a trans-Australia collaboration

2024

Conference Publication

Effectiveness of autologous haematopoietic stem cell transplantation in comparison with immune-reconstitution therapies in relapsing-remitting MS

Kalincik, Tomas, Sharmin, Sifat, Roos, Izanne, Freedman, Mark S., Atkins, Harold, Massey, Jennifer, Sutton, Ian, Withers, Barbara, Burman, Joachim, Torkildsen, Oivind, Bo, Lars, Lehmann, Anne Kristine, Havrdova, Eva, Krasulova, Eva, Trneny, Marek, Kozak, Tomas, Macdonell, Richard, Brown, William, Coles, Alasdair, Van der Walt, Anneke, Butzkueven, Helmut, Van Wijmeersch, Bart, Lechner-Scott, Jeannette, Barnett, Michael, Laureys, Guy, Van Hijfte, Liesbeth, Willekens, Barbara, Buzzard, Katherine, Skibina, Olga ... Snowden, John (2024). Effectiveness of autologous haematopoietic stem cell transplantation in comparison with immune-reconstitution therapies in relapsing-remitting MS. 40th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Copenhagen Denmark, Sep 18-20, 2024. LONDON: SAGE PUBLICATIONS LTD.

Effectiveness of autologous haematopoietic stem cell transplantation in comparison with immune-reconstitution therapies in relapsing-remitting MS

2024

Conference Publication

Driving forces: Investigating Menopause's Influence on MS Disability Progression

Bridge, Francesca, Sanfilippo, Paul, Skibina, Olga, Nguyen, Ai-Lan, Kalincik, Tomas, Buzzard, Katherine, Taylor, Bruce, MacIntyre, Jennifer, Hall, Lesley-Ann, Slee, Mark, Macdonell, Richard, Maltby, Vicki, Lechner-Scott, Jeannette, McCombe, Pamela, Butzkueven, Helmut, van der Walt, Anneke and Jokubaitis, Vilija (2024). Driving forces: Investigating Menopause's Influence on MS Disability Progression. 40th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Copenhagen Denmark, Sep 18-20, 2024. LONDON: SAGE PUBLICATIONS LTD.

Driving forces: Investigating Menopause's Influence on MS Disability Progression

2024

Conference Publication

Preserving neurological function in patients at high risk and low risk of aggressive MS

Roos, Izanne, Sharmin, Sifat, Ozakbas, Serkan, Alroughani, Raed, Ayuso, Guillermo Izquierdo, Madueno, Sara Eichau, Grand'Maison, Francois, Boz, Cavit, Lechner-Scott, Jeannette, Buzzard, Katherine, Skibina, Olga, Prat, Alexandre, Girard, Marc, Duquette, Pierre, Yamout, Bassem I., Khoury, Samia, Grammond, Pierre, van der Walt, Anneke, Butzkueven, Helmut, Blanco, Yolanda, Foschi, Matteo, Surcinelli, Andrea, Soysal, Aysun, Barnett, Michael, Prevost, Julie, Terzi, Murat, Gerlach, O., Macdonell, Richard, Sa, Maria Jose ... Kalincik, Tomas (2024). Preserving neurological function in patients at high risk and low risk of aggressive MS. 40th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Copenhagen Denmark, Sep 18-20, 2024. LONDON: SAGE PUBLICATIONS LTD.

Preserving neurological function in patients at high risk and low risk of aggressive MS

2024

Conference Publication

Real-world experience with Cladribine (Mavenclad) in the MSBase registry

Butzkueven, Helmut, Spelman, Tim, Van der Walt, Anneke, Hodgkinson, Suzanne, Ozakbas, Serkan, Alroughani, Raed, Kalincik, Tomas, Eichau, Sara, Boz, Cavit, Buzzard, Katherine, Habek, Mario, John, Nevin, Kermode, Allan G., Foschi, Matteo, McCombe, Pamela, Gerlach, Oliver, Prevost, Julie, Meca-Lallana, Jose E., Lapointe, Emmanuelle and Jarvinen, Elina (2024). Real-world experience with Cladribine (Mavenclad) in the MSBase registry. 40th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), Copenhagen, Denmark, 18-20 September 2024. London, United Kingdom: Sage Publications.

Real-world experience with Cladribine (Mavenclad) in the MSBase registry

2024

Conference Publication

Individualised prediction of on-treatment relapse using pretreatment clinical data: an MSBase machine learning study

Kremler, Courtney, Imrie, Fergus, Barnett, Michael, Lechner-Scott, Jeannette, Hodgkinson, Suzanne, Buzzard, Katherine, Garber, Justin, Slee, Mark, Mccombe, Pamela, van der Walt, Anneke, Macdonell, Richard, Van Pesch, Vincent, Laureys, Guy, Willekens, Barbara, Prevost, Julie, Duquette, Pierre, Grammond, Pierre, Grand'Maison, Francois, Ampapa, Radek, Castillo-Trivino, Tamara, Eichau, Sara, Luis Sanchez, Jose, Tello, Cristinaramo, Blanco, Yolanda, Besora, Sarah, Gray, Orla, Cartechini, Elisabetta, Amato, Maria Pia, Spitaleri, Daniele L. A. ... Brown, J. William L. (2024). Individualised prediction of on-treatment relapse using pretreatment clinical data: an MSBase machine learning study. 40th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Copenhagen Denmark, Sep 18-20, 2024. LONDON: SAGE PUBLICATIONS LTD.

Individualised prediction of on-treatment relapse using pretreatment clinical data: an MSBase machine learning study

2024

Conference Publication

Practical Clinical Predictions: MSBase Validation of the DAAE Score, A Clinical Tool for Estimating Risk of Conversion to Secondary Progressive Multiple Sclerosis

Fuchs, Tom, Schoonheim, Menno, Uher, Tomas, Horakova, Dana, Havrdova, Eva Kubala, Jelgerhuis, Julia, Grammond, Pierre, Khoury, Samia, Sa, Maria Jose, Lorscheider, Johannes, Cartechini, Elisabetta, Maimone, Davide, Oreja-Guevara, Celia, D'hooghe, Marie, Fabis-Pedrini, Marzena, Oh, Jiwon, Lalive, Patrice, Willekens, Barbara, Ozakbas, Serkan, Eichau, Sara, Girard, Marc, Duquette, Pierre, Patti, Francesco, Alroughani, Raed, Lugaresi, Alessandra, Tomassini, Valentina, Terzi, Murat, Amato, Maria Pia, Kalincik, Tomas ... Weinstock-Guttman, Bianca (2024). Practical Clinical Predictions: MSBase Validation of the DAAE Score, A Clinical Tool for Estimating Risk of Conversion to Secondary Progressive Multiple Sclerosis. 40th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Copenhagen Denmark, Sep 18-20, 2024. LONDON: SAGE PUBLICATIONS LTD.

Practical Clinical Predictions: MSBase Validation of the DAAE Score, A Clinical Tool for Estimating Risk of Conversion to Secondary Progressive Multiple Sclerosis

2024

Conference Publication

A standardised definition of progression independent of relapse activity in multiple sclerosis

Mueller, Jannis, Sharmin, Sifat, Lorscheider, Johannes, Ozakbas, Serkan, Karabudak, Rana, Horakova, Dana, Weinstock-Guttman, Bianca, Shaygannejad, Vahid, Etemadifar, Masoud, Boz, Cavit, Alroughani, Raed, Patti, Francesco, Izquierdo Ayuso, Guillermo, Eichau Madueno, Sara, Prat, Alexandre, Terzi, Murat, Lugaresi, Alessandra, Tomassini, Valentina, Kermode, Allan, Carroll, William, Grand'Maison, Francois, Amato, Maria Pia, Grammond, Pierre, Sajedi, Aidin, Turkoglu, Recai, Altintas, Ayse, Buzzard, Katherine, Skibina, Olga, Soysal, Aysun ... Kalincik, Tomas (2024). A standardised definition of progression independent of relapse activity in multiple sclerosis. 40th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Copenhagen Denmark, Sep 18-20, 2024. LONDON: SAGE PUBLICATIONS LTD.

A standardised definition of progression independent of relapse activity in multiple sclerosis